Úc - Tiếng Anh - APVMA (Australian Pesticides and Veterinary Medicines Authority)

draslovka services pty ltd - ethanedinitrile - pressurised gas - ethanedinitrile gas active 1000.0 g/kg - mixed function pesticide - felled log, post and pole | timber | log | pole | post | wood - insect pest of timber | wood fungus | borers | lyctids | quarantine timber insects | termite | timber destroying insects | wood decaying fungi | wood rot | wood rotting fungi | wood staining fungi | wood-destroying fungi

Úc - Tiếng Anh - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nufarm australia limited - diquat present as diquat dibromide; paraquat present as paraquat dichloride - soluble concentrate - diquat present as diquat dibromide pyridine-bipyridyl active 115.0 g/l; paraquat present as paraquat dichloride pyridine-bipyridyl active 135.0 g/l - herbicide - around established trees | avocado | barley - see label | canola - see label | cereal rye - see label | chickpea - see label | c - african turnip weed - seedling | annual grasses - see label | annual ground cherry | annual or wimmera ryegrass - seedling | annual pasture | annual saltbush - seedling | annual weeds | annual weeds - see label | australian bindweed - seedling | australian bluebell - seedling | awnless barnyard grass - seedling | ball mustard - seedling | barley grass - seedling | barnyard grass - seedling | barnyard grass or water grass | barnyard or water grass - seedling | bathurst burr - seedling | bedstraw seedling | bellvine - seedling | bifora - seedling | black pigweed - seedling | blackberry nightshade - seedling | bladder ketmia | bladder ketmia - seedling | bluetop - seedling | boggabri weed | broadleaf weeds | broadleaf weeds - see label | broadleaf weeds and grasses - see label | brome grass - seedling | buffel grass - seedling | calopo - seedling | caltrop or yellow vine - seedling | capeweed | capeweed - seedling | caustic weed - seedling | charlock - seedling | climbing buckwheat - seedling | clover | columbus

Úc - Tiếng Anh - APVMA (Australian Pesticides and Veterinary Medicines Authority)

redox limited - aluminium phosphide - tablet (inc. pellet, bolus, suppository, capsule) - aluminium phosphide mineral-aluminium active 560.0 g/kg - mixed function pesticide - stored barley seed | stored breakfast cereal | stored bulk stock feed | stored cereal grain | stored cereal produce | stored coc - stored commodity pests

Úc - Tiếng Anh - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sunzon international inc - aluminium phosphide - tablet (inc. pellet, bolus, suppository, capsule) - aluminium phosphide mineral-aluminium active 330.0 g/kg - insecticide - food product/commodity | grain handling machinery | shed,factory,warehouse or other building | stored barley seed | stored break - angoumois grain moth | bean weevil | cadelle | cigarette beetle | cockroach | coffee bean weevil | confused flour beetle | dried fruit beetle | flat grain beetle | granary weevil | hide or skin beetle | indian meal moth | lesser grain borer | maize weevil | mediterranean flour moth | merchant grain beetle | mottled grain moth | mouse - mus spp. | psocids or booklouse | raisin moth | rat | redlegged ham beetle | rice weevil | rust-red flour beetle | sawtoothed grain beetle | spider beetle | stored product mite | tobacco moth | tropical warehouse moth | warehouse beetle | dermestes ater | dermestes maculatus | grain borer | large cockroach | small cockroach | tobacco beetle

Israel - Tiếng Anh - Ministry of Health

glaxo smith kline (israel) ltd - zidovudine - solution for infusion - zidovudine 200 mg / 20 ml - zidovudine - zidovudine - retrovir iv for infusion is indicated for the short term management of serious manifestations of human immunodeficiency virus (hiv) infection in patients with acquired immuno deficiency syndrome (aids) or aids who are unable to take retrovir oral formulations.retrovir chemoprophylaxis, is indicated for use in hiv-positive pregnant women (over 14 weeks of gestation) for prevention of maternal-foetal hiv transmission and for primary prophylaxis of hiv infection in newborn infants. retrovir i.v. should only be used when oral treatment is not possible (except during labour and delivery).

Vương quốc Anh - Tiếng Anh - myHealthbox

dr. reddy’s laboratories (uk) ltd - docetaxel - concentrate for solution for infusion (sterile concentrate) - 20mg/ml - taxanes - in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with: • operable node-positive breast cancer • operable node-negative breast cancer.

Liên Minh Châu Âu - Tiếng Anh - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - ipilimumab - melanoma; carcinoma, renal cell; carcinoma, non-small-cell lung; mesothelioma, malignant; colorectal neoplasms - antineoplastic agents - melanomayervoy as monotherapy or combination with nivolumab is indicated for the treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older (see section 4.4). yervoy in combination with nivolumab is indicated for the treatment of advanced (unresectable or metastatic) melanoma in adults.relative to nivolumab monotherapy, an increase in progression-free survival (pfs) and overall survival (os) for the combination of nivolumab with ipilimumab is established only in patients with low tumour pd-l1 expression (see sections 4.4 and 5.1).renal cell carcinoma (rcc)yervoy in combination with nivolumab is indicated for the first-line treatment of adult patients with intermediate/poor-risk advanced renal cell carcinoma (see section 5.1).non-small cell lung cancer (nsclc)yervoy in combination with nivolumab and 2 cycles of platinum-based chemotherapy is indicated for the first-line treatment of metastatic non-small cell lung cancer in adults whose tumours have no sensitising egfr mutation or alk translocation.malignant pleural mesothelioma (mpm)yervoy in combination with nivolumab is indicated for the first-line treatment of adult patients with unresectable malignant pleural mesothelioma.mismatch repair deficient (dmmr) or microsatellite instability-high (msi-h) colorectal cancer (crc)yervoy in combination with nivolumab is indicated for the treatment of adult patients with mismatch repair deficient or microsatellite instability-high metastatic colorectal cancer after prior fluoropyrimidine based combination chemotherapy (see section 5.1).oesophageal squamous cell carcinoma (oscc)yervoy in combination with nivolumab is indicated for the first-line treatment of adult patients with unresectable advanced, recurrent or metastatic oesophageal squamous cell carcinoma with tumour cell pd-l1 expression ≥ 1%.

Liên Minh Châu Âu - Tiếng Anh - EMA (European Medicines Agency)

neovii biotech gmbh - catumaxomab - ascites; cancer - other antineoplastic agents - removab is indicated for the intraperitoneal treatment of malignant ascites in patients with epcam-positive carcinomas where standard therapy is not available or no longer feasible.,

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - capecitabine, quantity: 150 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; hypromellose; magnesium stearate; lactose; titanium dioxide; iron oxide yellow; purified talc; iron oxide red - colon cancer ,capecitabine is indicated for the adjuvant treatment of patients with dukes stage c and high-risk stage b, colon cancer, either as monotherapy or in combination with oxaliplatin.,colorectal cancer,capecitabine is indicated for the treatment of patients with advanced or metastatic colorectal cancer.,oesophagogastric cancer,capecitabine is indicated for the first-line treatment of patients with advanced oesophagogastric cancer in combination with a platinum-based regimen.,breast cancer,capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline-containing chemotherapy regimen unless therapy with these and other standard agents are clinically contraindicated ,capecitabine in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - capecitabine, quantity: 500 mg - tablet, film coated - excipient ingredients: lactose; magnesium stearate; microcrystalline cellulose; hypromellose; croscarmellose sodium; titanium dioxide; iron oxide yellow; purified talc; iron oxide red - colon cancer capecitabine is indicated for the adjuvant treatment of patients with dukes stage c and high-risk stage b, colon cancer, either as monotherapy or in combination with oxaliplatin.,colorectal cancer,capecitabine is indicated for the treatment of patients with advanced or metastatic colorectal cancer.,oesophagogastric cancer,capecitabine is indicated for the first-line treatment of patients with advanced oesophagogastric cancer in combination with a platinum-based regimen.,breast cancer,capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline-containing chemotherapy regimen unless therapy with these and other standard agents are clinically contraindicated ,capecitabine in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy.